Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Sale-Or-Purchase-of-Stock" stands at -1.36 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025.
Sino Biopharmaceutical Ltd's second quarter result of -0.055 Billion HKD for the item "Sale Or Purchase of Stock" represents no change compared to it's first quarter result.
Also, Sino Biopharmaceutical Ltd's second quarter result of -0.055 Billion HKD for the item "Sale Or Purchase of Stock" represents an increase of 69.58 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sino Biopharmaceutical Ltd's second quarter result of -1.36 Billion HKD for the item "Sale Or Purchase of Stock" represents an increase of 8.45 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.6043 Billion Hong Kong Dollars compared to the value the year prior.
The 1 year change is -0.6043 Billion Hong Kong Dollars.
The 3 year change is -0.22 Billion Hong Kong Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Sale Or Purchase of Stock | 905,699,262,464.00 |
![]() | Johnson & Johnson - Sale Or Purchase of Stock | 486,508,953,600.00 |
![]() | AbbVie Inc - Sale Or Purchase of Stock | 399,570,305,024.00 |
![]() | Roche Holding AG - Sale Or Purchase of Stock | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Sale Or Purchase of Stock | 280,205,508,085.11 |